Endotoxin (lipopolysaccharide, LPS) 1 is selectively mitogenic for a subpopulation of B lymphocytes, but is not directly mitogenic on peripheral or thymus T lymphocytes (1-6). On the other hand, the adjuvant effects of LPS in vivo in enhancing antibody formation may involve T lymphocytes (7-11). LPS effects on in vitro antibody production and B-cell mitogenesis (12) 
modification of the technique of Julius et al (21) . 1.5-2.5 × l0 s cells were first passed through glass wool at room temperature, then resuspended in 2 ml of media (RPMI containing 10% fetal calf serum [Gibco] ), and added to a washed prewarmed nylon wool column. An additional 1 ml of media was used to wash the cells into the column. The filled column was resealed loosely and incubated for 45-60 rain at 37°C in 5% CO2. Cells not adherent to nylon were harvested by dropwise elution with 20 ml warm medium. Another 15 ml media was passed through the column, and the loosely adherent cells ("retarded") were removed by a modified form of the Handwerger and Schwartz technique (22) . 20 ml warm media was added to the column, and then the nylon wool was squeezed with the syringe plunger. This was repeated three times with 5-ml vol of medium, and then twice again, after turning the nylon wool over. The samples of each fraction were pooled, washed, and the cells resuspended in complete medium.
Microplate Culture System. The method employed has been described in detail elsewhere (23) . [3H]thymidine ([3H]TdR) incorporation was assayed as described previously (23) . Culture results are expressed in terms of mean cpm/culture -SE for quadruplicate cultures.
Medium-RPMl. 1640 medium, to which 100 U of penicillin, 100 gg streptomycin/ml, and Fungizone (Gibco) were added plus 5% heated (56°C for 30 rain) human serum, was used for final cultures in all experiments. Mitomycin C (Nutritional Biochemicals, Cleveland, Ohio) was used to block thymidine incorporation in some experiments at a concentration of 50 ttg/0.1 ml per 15 × 10 e cells/0.5 ml, incubated at 37°C for 30 rain. The cells were washed three times with RPMI-1640 and resuspended in culture medium. Irradiation: 1,000 R was delivered to cell suspensions by a ~37Cs source.
Determination ofT6 Chromosome Marker. Cultures prepared as described above were treated with colcemid (Gibco) 0.4 ~g/ml 4 h before harvest, then washed in Hanks' balanced salt solution (BSS) (Gibco), and resuspended for 15 min in hypotonic BSS (24) . Cells were then centrifuged and resuspended in a cold methanol:acetic acid mixture (1:3) for 15 min. The fixed preparation was again centrifuged and resuspended in two drops of the fixative, placed on a clean microscope slide, and flamed briefly burning off the methanol. The slides were stained with Giemsa stain, and metaphases were identified and counted. Only those mitotic figures allowing full visualization of all chromosomes were evaluated. Approximately one-half of the metaphases in such preparations were unsatisfactory for evaluation.
Results

LPS-Induced Proliferation of Thymus Cells in the Presence of Peripheral
Lymphoid Cells. The basic observation explored in the series of experiments to be described is that cultures of mouse thymus cells, which proliferate minimally or not at all in response to LPS (4), appear to do so strongly when numbers of peripheral lymphoid cells too low to respond detectably are added. Table I shows four experiments typical of the range of proliferative responses observed when thymus cells and spleen cells were combined in a 25:1 ratio in the presence of LPS. The cultures containing thymus lymphocytes alone proliferate minimally; when splenic lymphocytes are added in numbers that respond minimally to LPS alone, a highly significant amplification of proliferation appears. This apparent synergistic effect is dependent upon the ratio between the cells of the mixture and the amount of LPS added. Dose-response kinetics, explored through experiments such as that illustrated in Fig. 1 , resemble those of B-cell mitogens rather than T-cell mitogens (25) . That is, a linear relationship was found between dose and degree of [3H]TdR incorporation at low LPS levels reaching a plateau at high ranges, without a significant inhibitory effect upon further addition of LPS.
When lymph node (LN) cells were used as a peripheral cell source, similar amplified proliferation occurred in LPS-stimulated cultures (Table I ). The doseresponse kinetics (Fig. 1) were similar to those seen using spleen cells. On the other hand, synergistic effects of LN cells at various ratios had kinetics somewhat different from that of spleen cells (Figs. 2, 3) . At high peripheral cell:thymus ratios, proliferation of spleen, but not LN cells alone, masked any synergism that may have occurred. Table II summarizes this group of experiments in terms of an amplification index. The synergy occurring with spleen cells was greatest at ratios between 1:0.1 and 1:0.04. When the thymus cell concentrations were varied, but the peripheral cell concentration was kept constant (Fig. 4) , proliferation in the resultant mixture was approximately proportional to the number of thymus cells added. This suggests that a cell component of the thymus population was the limiting element in the combined responses. When peripheral cell concentrations were varied and thymus remained constant under the same culture conditions (Table  II) , different kinetics emerged; high cell concentrations usually inhibited or reduced thymus/peripheral cell synergy.
Synergy Requires that Both Thymus and Peripheral Cells Proliferate.
To determine the contribution of each cell type to the augmented reaction, the thymus or the spleen cell component was either treated with mitomycin C (26) or irradiated (25) before culture (Table III) . When proliferation was inhibited in either cell component the synergistic two-cell response to LPS was essentially eliminated. The spleen cell contribution appeared more sensitive to block than that of the thymus; when blocked spleen cells were combined with thymus, proliferation was reduced to the level of thymus cells alone. When blocked thymus cells were combined with spleen cells, the combination retained the response expected of that number of spleen cells alone. It was concluded that the synergistic effect observed involves proliferation of both cellular elements.
Subpopulation Characteristics of Cells in the Proliferating Thymus Component.
Immunocompetent thymus cells constitute a minor subpopulation identified by responsiveness to T mitogens and alloantigens, graft-versus-host reactivity, low net density, low Thy-1, and high H-2 antigen distribution. The major subpopulation has high net density and high membrane Thy-1 antigen, but has none of those attributes that indicate immunocompetence (26, 27) . To determine which thymus subpopulation was involved in synergistic proliferation, the cells were selected either on the basis of density on BSA gradients or selection with anti-Thy-l.2 antisera and complement. Table IV illustrates the findings. Selective elimination of cells highly sensitive to anti-Thy-l.2 and C' yielded a subpopulation in which Con A responsiveness was apparently concentrated, but in which the capacity to support synergistic proliferation remained equivalent to whole unfractionated thymus. This suggested that the functions involving synergy are independent of Con A responsiveness. Cells active in promoting synergy were found at all density levels in BSA gradients ( Fig. 5) , although any direct LPS activity observed in thymus cells alone was limited to cells of lowest net density (26, 27) . Low density thymus fractions cultured with peripheral cells and LPS gave synergy not significantly greater than that given by high density fractions. Selective elimination of high Thy-l.2 cells from the high-density fractions with dilute anti-Thy-l.2 plus C' yielded a residual subpopulation of 20-30% of cells which supported synergy as well as the untreated fraction. Higher concentrations of anti-Thy-l.2 eliminated all cells in this fraction.
The thymus cell subpopulation participating in the synergistic effect can therefore be characterized as one having relatively low Thy-l.2 representation, variable net density, and of a different subclass from those cells that respond strongly to Con A.
Characteristics of the Proliferating Peripheral Lymphoid Cell Population.
The peripheral cell involved in the synergy effect was examined for properties of adherence to glass or nylon and for sensitivity to anti-Ig, anti-IgG, anti-IgM, or anti-Thy-l.2 plus C'. Table V shows that both adherent and nonadherent spleen cells had essentially equal activity in combination with thymus cells, while the nonadherent subpopulation had slightly lower levels of response to LPS alone. Nylon-column separation (Table VI) concentrated the proliferating peripheral cell in the retarded fraction. The cell population retarded by nylon had been previously filtered through glass wool, thus essentially eliminating a role of macrophages that are reported to potentiate T-cell functions in other contexts (28) (29) (30) (31) . The retarded subpopulation appeared directly responsive to LPS to a degree equal to that of the unseparated cells and contained cells giving synergistic activity when combined with thymus cells. Selection of cell populations by treatment with anti-Ig, anti-IgG, or anti-IgM plus C' reduced LPS-induced proliferation and eliminated most B-cell functions
Fro. 4 . Effect of varying thymus cell concentration on synergy. 5 x 104 spleen cells were cultured with 5 ~tg LPS alone and with thymus cells in the indicated concentrations.
[3H]TdR incorporation was measured over the last 24 h of a 72-h culture period and represented as mean cpm -+ SE for quadruplicate. Thymus + LPS (e); thymus + spleen + LPS (©). Table VII , tllis treatment both reduced drastically the LPS response level of spleen cells and essentially eliminated synergistic proliferation with thymus cells. Anti-Thy-l.2 and complement used in similar experiments either had no effect or in some cases enhanced synergistic proliferation (Table VIII) .
(32). As is illustrated in
Comparison of the Contribution of LPS Responder or Nonresponder Status to the Synergy Effect.
Spleen cells from C3H/HeJ mice are low responders to LPS, in contrast to most C3H strains (33) (34) (35) . Combinations of thymus and spleen from the low-responder strain (C3H/HeJ) with cells from a closely related and non-MLR reactive high-responder strain (C3Heb/FeJ) were tested to determine how responder status contributed to synergistic proliferation in the system. It is evident from Table IX that the synergy effect occurs only when the peripheral component is of responder origin. The thymus cell component did not require responder status. These results are interpreted to mean that the peripheral cell must be LPS responsive to be synergistic with T cells.
Karyotypic Analysis Using Mixtures of T6 and Non-T6 Thymus and Spleen Cells. The relative contribution of each cell component to synergistic proliferation was resolved using CBA/H-T6J (T6) and CBA/Caj (Ca) histocompatible thymus and spleen combinations (Table X) . Either T6 thymus or spleen cells were cultured together with Ca thymus or spleen cells, and after 72 h, the presence of the T6 markers was determined in each satisfactory metaphase. Replicative cultures were assayed for [3H]TdR incorporation.
The thymus cell contribution, although detectable in every culture, proved to be minimal. Only 2-10% of the tota] dividing cells in cultures showing augmented proliferation in response to LPS were of thymus origin. 90-98% of proliferating cells in the synergistic cultures were of peripheral cell origin.
Discussion
The data presented demonstrate that synergistic proliferation occurs when a low Thy-1, non-Con A responsive thymus T-cell subpopulation is cultured with small numbers of peripheral B cells in the presence of LPS. Synergy requires 
Low density thymus (C') (5 x los)
Low density thymus (anti-Thy-I. 2 plus C' treated) (5 × los) 
High density thymus (C') (5 x los)
High density thymus (anti-Thy-l.2 plus The data available permit construction of a working hypothesis involving a sequence of cellular interactions. Briefly, the first step is postulated to involve direct LPS stimulation of the small subpopulation of peripheral B cells added to the mixture. As a result of this stimulation a subclass of thymus T cells is activated. The activated T cells in some way exert a stimulatory or regulatory effect on the ongoing LPS-induced B-cell proliferation which greatly increases the level of [3H]TdR incorporation finally measured.
The initial step appears to be a direct B-mitogen effect because (a) the thymus component does not respond to LPS directly, and (b) the B-cell-containing population is known to respond to LPS without any helper cell requirement (37, 38) . The next step is postulated to involve activation of the thymus cell component because (a) synergy requires these T cells and (b) supernates from LPS-stimulated peripheral B cells cause proliferation of high-density thymus cells with Tcell-like kinetics (M. A. Norcross and R. T. Smith, unpublished data). It is unlikely that this factor is macrophage derived, as is apparently true of the lymphocyte stimulating factor (LAF) described by others (28) (29) (30) . Both the peripheral population involved and the thymus cells can be completely depleted of macrophages without interfering with synergy. A very small proportion of B cells (less than 5% of the cultured cell mixture) is required to activate the thymus cell component. Conceivably, apparent macrophage effects seen in other systems could be explained through the contribution of small numbers of B cells in the adherent cell fractions employed as a macrophage source.
In the last proposed step the activated T-cell component augments or regulates ongoing B-cell proliferation stimulated by LPS. This regulatory effect might occur (a) by recruiting previously unresponsive B cells; (b) by nonspecifically facilitating proliferation of cells already dividing; or (c) by releasing B cells from suppression. In any case, the B cells in the augmented response could be responding to a T-cell product alone, to LPS, or to both.
If the artificial system we have described is interpreted correctly, perhaps an analogous peripheral T-cell component regulates B-cell responses to LPS in peripheral lymphoid tissues. Tumor-bearing mice and Bacille Calmette Guerintreated mice show greatly augmented LPS responses in regional lymph nodes, far in excess of any increase in T-or B-cell numbers in those nodes (23) . This could represent an in vivo reflection of the in vitro phenomenon described. However, this does not appear congruent with the observation (5) that peripheral lymphoid cells pretreated with anti-0 and C' either show comparable or enhanced LPS proliferation in the residual population. The known subclasses of peripheral T cells are quite sensitive to anti-Thy-1 and C' treatment; a diminished response therefore would be expected unless a suppressor T cell were also eliminated or a helper cell were concentrated. Pre-T cells are present in spleen and bone marrow of the normal mouse, but not in peripheral blood or lymph nodes. Both of these cell populations are poor responders to LPS (39) . Pre-T cells are found in spleens of both nude (40) or thymectomized (41) mice which show excellent LPS responses. Pre-T cells, if exposed to thymosin, develop characteristic thymus antigens (41, 42) . It seems possible that the pre-T cell might provide an equivalent of the amplifier thymus cell subpopulation in augmenting LPSinduced B-cell proliferation. Attempts to identify a T-regulatory cell among peripheral lymphoid cells are in progress.
Summary
When thymus cells which are unresponsive to LPS are combined with numbers of peripheral lymphoid cells giving minimal responses to LPS, synergistic incorporation of [3H]thymidine occurs. Synergy requires that both components proliferate, but most of the augmented response is the result of peripheral cell proliferation. The thymus cell is a T cell of variable density, low in thy-l.2 antigen, not concanavalin A responsive, present in the major thymus subpopulation, and may be from lipopolysaccharide (LPS)-unresponsive strains. The peripheral cell is sensitive to anti-IgG or IgM plus complement (C'), resistant to anti-Thy-l.2 and C', exhibits adherence properties of B lymphocytes, and must be from LPS-responsive strains. Synergistic responses depend on critical thymus/peripheral cell ratios, inhibition occurring at high peripheral cell numbers. The data provide evidence that B-cell proliferative responses to LPS may be regulated by a subclass of thymus T cells.
